Strs Ohio Decreases Holdings in GE HealthCare Technologies Inc. $GEHC

Strs Ohio decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.2% in the first quarter, Holdings Channel reports. The fund owned 299,148 shares of the company’s stock after selling 41,716 shares during the quarter. Strs Ohio’s holdings in GE HealthCare Technologies were worth $21,293,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $26,000. Optima Capital LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Godfrey Financial Associates Inc. purchased a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Montag A & Associates Inc. boosted its holdings in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Peter J. Arduini acquired 4,169 shares of the stock in a transaction on Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the transaction, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO James Saccaro bought 3,310 shares of the company’s stock in a transaction on Friday, May 1st. The stock was bought at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the purchase, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 21,847 shares of company stock valued at $1,361,355. Company insiders own 0.36% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Wells Fargo & Company decreased their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Rothschild & Co Redburn cut their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 15th. Mizuho lowered their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Finally, JPMorgan Chase & Co. dropped their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Ten analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $80.20.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $65.57 on Friday. The stock has a 50 day moving average price of $63.70 and a 200 day moving average price of $73.29. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The firm has a market capitalization of $29.83 billion, a P/E ratio of 15.69, a P/E/G ratio of 1.78 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period last year, the company earned $1.01 EPS. The business’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s payout ratio is currently 3.35%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.